Mast Therapeutics, Inc. (NYSE MKT:MSTX), announced that it will hold a conference call at 8am Eastern Time, 5am Pacific Time on Tuesday, January 6, 2015. The Company intends to provide an update on EPIC, its pivotal phase 3 study of its lead product candidate vepoloxamer (MST-188) in sickle cell disease, which the Company continues to expect will complete enrollment by the end of 2015, and anticipated clinical and business milestones for 2015. Mast Therapeutics, Inc. (NYSEMKT:MSTX) belongs to Healthcare sector. Its weekly performance is 21.74%. On last trading day company shares ended up $0.56. Mast Therapeutics, Inc. (NYSEMKT:MSTX) distance from 50-day simple moving average (SMA50) is 16.33%.
Whiting Petroleum Corp (NYSE:WLL)‘s stock had its “outperform” rating reissued by investment analysts at Oppenheimer in a note issued to investors on Tuesday. They currently have a $40.00 target price on the stock. Whiting Petroleum Corp. (NYSE:WLL) shares decreased -1.58% in last trading session and ended the day at $33.00. WLL Gross Margin is 82.10% and its return on assets is 3.90%. Whiting Petroleum Corp. (NYSE:WLL) quarterly performance is -55.31%.
On Dec 15, bebe stores, inc. (NASDAQ:BEBE) announced that Jim Wiggett has been named Chief Executive Officer and appointed to the Company’s Board of Directors, effective immediately. Jim has been serving as Interim Chief Executive Officer since June 2014. On 31 December, Bebe Stores, Inc. (NASDAQ:BEBE) shares decreased -2.23% and was closed at $2.19. BEBE EPS growth in last 5 year was -41.00%. Bebe Stores, Inc. (NASDAQ:BEBE) year to date (YTD) performance is -57.97%.
Mallinckrodt PLC (NYSE:MNK) VP Peter G. Edwards sold 1,265 shares of the company’s stock on the open market in a transaction that occurred on Monday, December 22nd. The stock was sold at an average price of $99.69, for a total value of $126,107.85. Following the completion of the sale, the vice president now directly owns 15,167 shares of the company’s stock, valued at approximately $1,511,998. Mallinckrodt PLC (NYSE:MNK) ended the last trading day at $99.03. Company weekly volatility is calculated as 1.98% and price to cash ratio as 16.27. Mallinckrodt PLC (NYSE:MNK) showed a weekly performance of 0.92%.
Bank of the Ozarks, Inc. (NASDAQ: OZRK) and Intervest Bancshares Corp. (NASDAQ:IBCA) jointly announced that the companies expect the previously announced merger transaction will close on or about February 10, 2015, subject to satisfaction of the remaining closing conditions set forth in the merger agreement, including the approval and adoption of the merger agreement by Intervest’s stockholders at the special meeting of stockholders scheduled for January 27, 2015. All required regulatory approvals for the merger of Intervest with and into Ozarks have been received. Intervest Bancshares Corp. (NASDAQ:IBCA) shares decreased -0.10% in last trading session and ended the day at $10.05. IBCA return on assets is 1.10%. Intervest Bancshares Corp. (NASDAQ:IBCA) quarterly performance is 5.90%.